US2012259091A1PendingUtilityA1

Apolipoprotein A1 Mimetics and Uses Thereof

53
Individually held — no corporate assignee on recordPriority: Jul 16, 2004Filed: Feb 28, 2012Published: Oct 11, 2012
Est. expiryJul 16, 2024(expired)· nominal 20-yr term from priority
Inventors:William W. Bachovchin
A61P 9/12A61P 9/00A61P 3/06A61P 9/10C07K 14/775A61K 38/1709A61P 3/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides peptidomimetics derived from Apolipoprotein A-I, which is useful for beneficially influencing lipid parameters and/or plasma cholesterol levels. The invention also provides pharmaceutical compositions and methods of treatment for elevated levels of plasma cholesterol.

Claims

exact text as granted — not AI-modified
1 . A peptidomimetic with a substantially similar three-dimensional conformation as a peptide comprising the D-amino acid sequence F-A-E-KF-K-E-A-V-K-D-Y-F-A-K-F-W-D (SEQ ID NO:3). 
     
     
         2 - 18 . (canceled)

Join the waitlist — get patent alerts

Track US2012259091A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.